Bicara Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$22.01

-0.63 (-2.78%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 82%

Hold 4 18%

Sell 0 0%

Price Target

Analyst Price Target -34.1% upside

Low Target $9.75

Average Target $14.50

High Target $19.19

Current Price $22.01

Current
$22.01

Target
$14.50

$9.75 $14.50 avg $19.19

Scenario Analysis

Bear Case

$9.75

-55.7%

Low target

Base Case

$14.50

-34.1%

Avg target

Bull Case

$19.19

+-12.8%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$30.99

-29.0% from high

52-Week Low

$10.30

+113.8% from low

Target vs 52W High

$14.50

-53.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%